These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Studies of the mechanism of an antibacterial peptide (cecropinA-magainin) on methicillin-resistant Staphylococcus aureus membranes.
    Author: Yu L, Zhu M, Liu E, Yang T, Chen X, Wang X.
    Journal: Biotechnol Appl Biochem; 2016 Nov; 63(6):805-811. PubMed ID: 26265318.
    Abstract:
    As bacterial resistance becomes increasingly common, a new hybrid peptide, cecropinA-magainin (KWALSKEGPGKFLGKKKKF), has been developed that can kill a broad spectrum of bacteria without damaging human cells. The mechanism of antibacterial toxicity for the hybrid peptides is unknown. Herein, we investigate the localization of the hybrid peptide in methicillin-resistant Staphylococcus aureus (MRSA). The minimum inhibitory concentration was 64 µg/mL. The hybrid peptides could enhance the hydrophobicity of MRSA. Dye leakage experiments showed that the hybrid peptides caused dye leakage from liposomes. The hybrid peptides influenced the permeability of the outer membrane and plasma membrane of MRSA. After cecropinA-magainin treatment of MRSA, the membrane ultrastructure was damaged and the concentration of K+ increased. Ultimately, the peptide destroyed the integrity of the bacterial cell membrane, allowing the dye propidium iodide to enter the cytoplasm. Therefore, the hybrid antibacterial peptide can kill MRSA.
    [Abstract] [Full Text] [Related] [New Search]